Johnson and Johnson Covid Vaccine: The US is considering measures to jointly produce Johnson & Johnson’s Kovid-19 vaccine in India and to help manufacturers such as the Serum Institute of India (SII) increase production. Daniel B. Smith, mission in-charge of the US Embassy, said this on Tuesday. Smith also said that the effectiveness of AstraZeneca’s Kovid-19 vaccine produced at the Baltimore plant has not yet been approved and the Food and Drug Administration has not yet certified the availability of doses for use or export.
The White House (the residence of the US President) said last month that it plans to distribute 6 million doses globally after the availability of the vaccine for Astrazenka. Of this, India is hoping to achieve a larger share. Speaking to reporters, Smith said that the United States is concerned about the current state of the epidemic in India. The reason for this is not only this human tragedy but also its global impact. The Biden administration stands firmly with India to deal with this crisis.
He said, “I know that Astrazenka vaccines are being produced in the US.” It is produced at a plant located on the outskirts of Baltimore. But there is a problem with this plant. So far, the US Food and Drug Administration has not certified whether these vaccines are available for anyone’s use and export. “He was asked if the US would make AstraZenca vaccines available to India as soon as possible.” He said, “That is why I cannot say when these things will happen or what will happen …”.
Bharat Biotech started sending Kovaxin to 18 states, see if your state name is in the list or not!
Smith, who was recently acting Foreign Minister and Acting Deputy Foreign Minister, has been appointed as mission in-charge at the US Embassy in India. They have to primarily watch and coordinate US aid to India to deal with the epidemic. In response to a question related to joint production, he said that it takes time to establish joint production. America is looking at how it can invest to increase production.
Smith said, “Our development finance cooperation is looking at how we can invest, which can help produce Johnson & Johnson vaccines in India….” India’s role in the production of Kovid-vaccines at the level is quite significant. “We are looking at production levels at SII and elsewhere,” Smith said. We are in touch with SII and are trying to decide what raw material we can provide so that production can be increased. ”
WHO on Corona Deaths in India: Advice of Chief Scientist Soumya Swaminathan – Governments should present correct figures of Corona
Disclaimer: This post has been auto-published from an agency/news feed without any modifications to the text and has not been reviewed by an editor.